🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, dose escalation, phase I study of the combination of...
Status
Withdrawn
Location
Dartmouth-Hitchcock Medical Center
Start Date
2016-08
Trial ID
NCT03422874
Treatments Being Tested
This protocol is a randomized, open-label, national, multicenter trial stud...
Status
Completed
Location
Complejo Hospitalario Universitario de Santiago
Start Date
2014-11
Trial ID
NCT02406144
Treatments Being Tested
This study aims to evaluate the efficacy of BTK inhibitor Zanubrutinib comb...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2020-06-01
Trial ID
NCT04463953
Treatments Being Tested
Multiple myeloma (MM) is the second most common hematologic malignancy with...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-02
Trial ID
NCT06050512
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06-05
Trial ID
NCT04272775
Treatments Being Tested
The primary purpose of the trial is to determine the safety and tolerabilit...
Status
Completed
Location
Mayo Clinic
Start Date
2017-03-20
Trial ID
NCT02946047
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ixazomib ci...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2015-07-03
Trial ID
NCT02420847
Treatments Being Tested
This phase II trial studies the safety of alternating ixazomib citrate and ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2015-12-30
Trial ID
NCT02619682
Treatments Being Tested
The purpose of this study is to evaluate the effects, good and bad of a new...
Status
Unknown
Location
Northwestern University
Start Date
2015-10-28
Trial ID
NCT02481310
This phase 0 trial studies ixazomib citrate in treating patients with gliob...
Status
Completed
Location
Emory University/Winship Cancer Institute
Start Date
2016-03-24
Trial ID
NCT02630030
Treatments Being Tested